mtarget.com

biotechnology company focused on the development of diagnostic and therapeutic molecules to address the medical needs in cancer and cardiovascular diseases. Lead product candidates include PSVue and Tc-99m Duramycin. MTTI is also building a research reagents business and manufactures and sells an ever expanding portfolio of products, primarily based upon fluorescence, to meet the needs of cutting edge academic researchers